Suchergebnisse - "Dvorkin, Mikhail"

PubPharm (40)

11

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab : Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2021

von Syrigos, K. | Abert, I. | Andric, Z. | +13

12

Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer : a subgroup analysis from the phase 3 TAGS study

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Mansoor, W. | Arkenau, H. | Alsina, M. | +15

13

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)

enthalten in: BioDrugs | 2021

von Syrigos, K. | Abert, I. | Andric, Z. | +12

14

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)

enthalten in: BioDrugs | 2021

von Syrigos, K. | Abert, I. | Andric, Z. | +12

15

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)

enthalten in: BioDrugs | 2021

von Syrigos, K. | Abert, I. | Andric, Z. | +12

16

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Lee, N. | Ferris, R. | Psyrri, A. | +18

CommentIn: Lancet Oncol. 2021 Jul;22(7):e290. - PMID 34197752

17

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers : Results From JAVELIN Gastric 100

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Moehler, M. | Dvorkin, M. | Boku, N. | +18

18

Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study

enthalten in: Gastric cancer | 2021

von Mansoor, W. | Arkenau, H. | Alsina, M. | +15

19

Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study

enthalten in: Gastric cancer | 2021

von Mansoor, W. | Arkenau, H. | Alsina, M. | +15

20

Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study

enthalten in: Gastric Cancer | 2021

von Mansoor, W. | Arkenau, H. | Alsina, M. | +15